Stephen Strakowski, MD - MMHPI - Meadows Mental Health Policy Institute

Stephen Strakowski, MD

Senior Fellow for Psychiatric Innovation

Stephen M. Strakowski, MD, is Vice Dean of Research and Associate Vice President, Regional Mental Health at the Dell Medical School, University of Texas in Austin. He is also Professor of Psychiatry, Psychology and Educational Psychology at UT Austin, and previously served as Founding Chair of Psychiatry, to establish the new department. Dr. Strakowski was selected as the Inaugural Executive Director of The Mary O’Daniel Stone and Bill Stone Center for Child and Adolescent Psychiatry at Indiana University School of Medicine (IUSM), which is focused on expanding youth mental health services and research, especially related to bipolar disorder. He also serves as a professor in the Department of Psychiatry at the IU School of Medicine.

Dr. Strakowski spent 24 years at the University of Cincinnati/UC Health where he last served as Senior Vice President of Strategy and Transformation in UC Health and Professor of Psychiatry and Behavioral Neuroscience, Psychology and Biomedical Engineering. His work at the Meadows Institute is focused on providing strategic guidance regarding psychiatric clinical and policy best practices, including psychiatric programming, competency restoration, reimbursement, and care models for transition age youth. Additionally, Dr. Strakowski assists in the development of strategic partnerships with national leaders in psychiatry and university health systems.

Dr. Strakowski graduated summa cum laude from the University of Notre Dame with a BSE in 1984 and alpha omega alpha from Vanderbilt University School of Medicine with an MD in 1988. He completed his residency training at McLean Hospital/Harvard University School of Medicine in 1992. Upon completing residency, he moved to the University of Cincinnati where he remained until moving to the University of Texas. Dr. Strakowski is an internationally recognized and trusted expert in the study and treatment of bipolar and other mood disorders. His research group has been a world leader studying the treatment, outcomes and neurobiology of these conditions. He is recognized as a Best Doctor® and by US News and World Report® as a Top 1% Psychiatrist. He maintains an active clinical practice and research career.